Meeting | Mixed
Event Title
Patient Voice in Rare Disease Medical Product Development
October 16, 2026
Event Title
Patient Voice in Rare Disease Medical Product Development
- Date:
- October 16, 2026
- Time:
- 1:00 p.m. - 5:00 p.m. ET
- Location:
-
Event LocationAttend In Person or Online
Virtual: Via Zoom
In Person: FDA White Oak Campus
10903 New Hampshire Avenue
Building 31, Room 1503
Silver Spring, MD 20993
United States
Attend
On October 16, 2026, the U.S. Food and Drug Administration, in partnership with the Reagan-Udall Foundation for the FDA (Foundation), will convene a hybrid meeting to explore the patient voice in rare disease medical product development (biologic, drug, and device). The meeting will explore where the patient voice is sought across the development timeline, its impact, and additional opportunities for patients to engage in the product development process. Insights from these discussions will help inform recommendations for product developers and regulators to consider as they advance patient-centered approaches in their work.